The Growing Burden of Chronic and Infectious Diseases: Driving the Growth of the Real-world Evidence (RWE) Solutions Market in the U.S.
Clinical researchers often use real-world evidence (RWE) to enhance data from randomized controlled trials (RCTs). The 21st Century Cures Act has encouraged the U.S. Food and Drug Administration (FDA) to take a more active role in utilizing real-world data and Read More..
Potential For Real-world Evidence (RWE) Solutions In Healthcare
The increasing emphasis on personalized healthcare, along with challenges like delays in drug development and rising costs, has led to a surge in the use of real-world evidence (RWE) solutions. Additionally, the growing prevalence of chronic diseases, a shift towards Read More..